Clinical Trial Update: Efficacy and Safety of CDE100 in the Treatment of Menstrual Cramp Pain Associated With Primary Dysmenorrhea [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating the efficacy and safety of CDE100 for menstrual cramp pain in primary dysmenorrhea. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dysmenorrhea

Drugs mentioned

• CDE100

Snippet

Sponsor: EMS | Conditions: Primary Dysmenorrhea | Phase 3 | Status: RECRUITING